Fundraising Fox
Sanavia Oncology
Founded 2020 · 14 employees on LinkedIn · 1 known investors
Find your way into Sanavia Oncology
Sign up to see every warm intro you have to Sanavia Oncology
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Sanavia Oncology team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Sanavia discovers novel cancer-specific epitopes using proprietary immunization technology and AI to enable more effective antibody therapies for oncology. The company develops epitope discovery platforms and antibody drug candidates targeting multiple cancer types to expand treatment options for patients.
Investors · 1
Two Bear Capital✓ confirmed by Sanavia OncologyWhitefish · $3M – $10M
How we know: the company's own site · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Sanavia Oncology do?
- Sanavia discovers novel cancer-specific epitopes using proprietary immunization technology and AI to enable more effective antibody therapies for oncology. The company develops epitope discovery platforms and antibody drug candidates targeting multiple cancer types to expand treatment options for patients.
- Who are Sanavia Oncology's investors?
- Sanavia Oncology's investors include Two Bear Capital.